Educational Grant Sponsors
AstraZeneca is a global, science-led biopharmaceutical company focused on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in 100+ countries and its innovative medicines are used by millions of patients worldwide.
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. We are focused on helping patients in disease areas including oncology, cardiovascular, immunoscience and fibrosis. Each day, our employees work together for patients – it drives everything we do.
MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. MedImmune is pioneering innovative research and exploring novel pathways across Oncology, Respiratory, Cardiovascular, Renal and Metabolic Diseases, and Infection and Vaccines.
For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, MSD continues be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.
One of the world’s leading research-based pharmaceutical and healthcare companies, GSK is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit our website.
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and specialty care. The group develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Diseases.
- Booth number: 8
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
- Booth number: 3
Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit SyneosHealth.com.
- Booth number: 4
Bavarian Nordic is a fully integrated company focused on innovative vaccines for cancer and infectious diseases. We have a diverse portfolio of cancer immunotherapies, designed to alter the disease course by eliciting a robust and broad anti-cancer immune response. Through industry collaborations, we seek to explore the potential synergies of combining our platform with other immune-modulating agents, e.g. checkpoint inhibitors.
- Booth number: 5
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Our belief—and the core of our strategy—is that innovative, highly differentiated medicines that provide large clinical benefits in addressing serious diseases are medicines that will not only help patients, but also will help reduce the social and economic burden of disease in society today.
Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. Globally, the oncology franchise at Bayer includes now five marketed products and several other compounds in various stages of clinical development. Together, these products reflect the company’s approach to research, which prioritizes targets and pathways with the potential to impact the way that cancer is treated
Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.
- Booth number: 1a
Pierre Fabre Laboratories
Pierre Fabre is a global player in pharmaceuticals and dermo-cosmetics, with revenues of 2,28 billion euros in 2016 and over 13,000 employees worldwide. In 2016, Pierre Fabre dedicated 178 million euros to R&D in 5 therapeutic areas: oncology, central nervous system, dermatology, dermo-cosmetics and dermo-cosmetics. Its brand Eau thermal Avène is the leading dermo-cosmetic brand in the world. A unique case in France, the company is majority-owned by the Pierre Fabre Foundation, a government-recognized public-interest organization.
Based on its in-house expertise in data management, biostatistics, medical writing and clinical operations, 4Clinics provides tailor-made clinical services. 4Clinics staff managed set-up and conduct activities of more than 500 trials, performed more than 300 clinical data analysis and wrote more than 750 clinical and regulatory documents for more than 300 pharmaceutical and biotechnology companies running clinical trials in oncology.
- Booth number: 1b
Adaptive Biotechnologies is a pioneer in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. Adaptive is bringing the accuracy and sensitivity of its immunosequencing platform into laboratories around the world to drive groundbreaking research in cancer and other immune-mediated diseases. Adaptive also translates immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care.
- Booth number: 2
Amoy Diagnostics Co., Ltd.
Amoy Diagnostics Co., Ltd. (AmoyDx) is a molecular diagnostic product manufacturer and service provider for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS and Super-ARMS, AmoyDx has a full portfolio of molecular diagnostics kits including but not limited to EGFR, ROS1 and approved by CFDA and CE-IVD.
- Booth number: 9
BlueDNAcompanion provides state-of-the-art molecular diagnostics (nucleic acid extraction, Q-PCR, NGS, Point of Care, digital PCR) and VOCs mass spectrometry. BlueDNAcompanion offers products and services to microbiologic and clinical laboratories, pathologists, pharmaceutical and biotech companies. In oncology BlueDNAcompanion gets focus on companion tests panels to detect somatic mutations, gene rearrangements, gene expression on FFPE samples and liquid biopsies.
- Booth number: 10
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. is a leader in innovative drug discovery and development, committed to the fight against cancer. Astex is developing a proprietary pipeline of novel therapies and has a number of products being developed in collaboration with leading pharmaceutical companies. Astex is a member of the Otsuka group of companies.
Janssen Research & Development, LCC
Let’s change what a cancer diagnosis means. Together. At Janssen, we’ve set our sights on making cancer a preventable and curable disease. To help achieve our vision, we partner with the world’s top minds, from academic institutions and patient advocates to companies large and small. We collaborate with the world for the health of everyone in it.